Because genome-wide methylation sequencing data showed no differential methylation in the HES1 promoter region in TOF patients, we hypothesized that HES1 non-coding sequence variants associated with the risk of CHD development might be present. This evidence concerns the gene HES1 and coronary artery disorder.